<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="The Attenuation Distribution Across the Long Axis (ADLA)" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/the-attenuation-distribution-across-the-long-axis-adla/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/the-attenuation-distribution-across-the-long-axis-adla/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2016-05-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="The Attenuation Distribution Across the Long Axis (ADLA)" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T03:59:08+00:00","datePublished":"2016-05-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"The Attenuation Distribution Across the Long Axis (ADLA)","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/the-attenuation-distribution-across-the-long-axis-adla/"},"url":"https://clinicaltree.github.io/posts/the-attenuation-distribution-across-the-long-axis-adla/"}</script><title>The Attenuation Distribution Across the Long Axis (ADLA) | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>The Attenuation Distribution Across the Long Axis (ADLA)</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>The Attenuation Distribution Across the Long Axis (ADLA)</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1464714000" data-df="ll" data-toggle="tooltip" data-placement="bottom"> May 31, 2016 </em> </span> <span> Updated <em class="" data-ts="1681099148" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Nikita Lakomkin</a> </em>, <em> <a href="">Hakmook Kang PhD</a> </em>, <em> <a href="">Bennett Lman PhD</a> </em>, <em> <a href="">M. Shane Hutson PhD</a> </em>, <em> <a href="">Richard G. Abramson MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1643 words"> <em>9 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Novel image analysis methods may be useful adjuncts to standard cancer treatment response assessment techniques. The attenuation distribution across the long axis (ADLA) is a simple measure of lesion heterogeneity that can be obtained while measuring the long axis diameter of a target lesion. The purpose of this study was to obtain preliminary validation of the ADLA method for predicting treatment response in a small clinical trial.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Under an Institutional Review Board waiver, we obtained de-identified imaging and clinical data from a phase 2 trial of an investigational anticancer therapy at our institution. We retrospectively analyzed all patients with at least one liver metastasis measuring ≥15 mm on baseline contrast-enhanced computed tomography. For each patient at every imaging time point, up to two target liver lesions were evaluated using Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 and ADLA measurements. The ADLA was obtained as the standard deviation of the post-contrast computed tomography attenuation values in the portal venous phase across a linear function spanning the long-axis diameter. Using Kaplan-Meier survival analysis, the log-rank test was used to evaluate the ability of RECIST 1.1 and ADLA measurements to discriminate patients with longer overall survival (OS).</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Fifteen patients met inclusion criteria. Median survival was 149 days (range 57-487). Best overall response by the ADLA method successfully separated patients with longer OS (p = .04). Best overall response by RECIST 1.1 did not discriminate patients with longer survival ( <em>P</em> &gt; .05).</p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>In retrospective data analysis from a phase 2 clinical trial, the ADLA method was more predictive of OS than RECIST 1.1. Further studies are needed to explore the utility of this measurement in predicting response to cancer treatment.</p><h2 id="introduction"><span class="mr-2">Introduction</span><a href="#introduction" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>In recent years, a number of imaging techniques have been proposed for the assessment and prediction of response to anticancer therapy. These proposals span multiple modalities and range from fully quantitative to semiquantitative approaches . They are linked by the common goal of assessing response earlier or more accurately than traditional lesion size-based response techniques, with the end objective of triaging patients quickly to more beneficial therapies and sparing patients harmful side effects from ineffective regimens . In order for new response assessment techniques to be successfully translated into clinical trials and routine clinical practice, the data extraction methods must not create an unreasonable workflow burden. Many fully quantitative techniques require significant time and resources for image processing and analysis. Although such techniques may be appropriate for a dedicated imaging core laboratory, their workflow requirements make their incorporation into routine clinical practice unlikely.</p><p>This paper introduces the attenuation distribution across the long axis (ADLA) as a simple and easily extracted semiquantitative imaging biomarker for assessing treatment response in solid malignancies. The ADLA, described in more detail later, is a measure of intralesional heterogeneity that can be obtained while measuring the long axis diameter of a target lesion on cross-sectional imaging. ADLA measurements may be easily obtained as part of the typical radiologist’s workflow. As a measure of intralesional heterogeneity, we hypothesize that the ADLA measurement is promising as a biomarker for treatment response under the assumption that viable tumors will have a heterogeneous distribution of postcontrast computed tomography (CT) attenuation values reflecting healthy perfused soft tissue, whereas tumors responding to therapy will have a more homogeneous attenuation distribution reflecting decreased tumor perfusion and intralesional necrosis. We believe that with proper validation, this metric may be incorporated into clinical trials and into routine clinical evaluation to help assess tumor response across a wide range of anticancer therapies. The purpose of this preliminary study was to illustrate the ADLA technique and to provide preliminary biomarker validation against survival end points using imaging data from a phase 2 clinical trial.</p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="patient-selection-and-data-collection"><span class="mr-2">Patient Selection and Data Collection</span><a href="#patient-selection-and-data-collection" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheAttenuationDistributionAcrosstheLongAxisADLA/0_1s20S1076633216001069.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheAttenuationDistributionAcrosstheLongAxisADLA/0_1s20S1076633216001069.jpg" alt="Figure 1, Depiction of the ADLA function drawn across the diameters of three lesions of varying heterogeneity along with the accompanying contrast histogram and standard deviations (lesions obtained from different patients for illustrative purposes). The ADLA measurement was obtained as the standard deviation of the postcontrast CT attenuation values in the portal venous phase across a linear function spanning the long-axis diameter of the lesion. The y -axis of the contrast histogram represents the number of pixels representing each contrast shade (shown on the x -axis)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="data-analysis"><span class="mr-2">Data Analysis</span><a href="#data-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-methods"><span class="mr-2">Statistical Methods</span><a href="#statistical-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Best Overall Response by ADLA and RECIST 1.1</p><p>Patient Number Maximum Change in Diameter (RECIST) Ψ Maximum Change in Weighted Average (ADLA) Ψ Best Overall Response RECIST 1.1 Best Overall Response ADLA Overall Survival (Days) 1 +17.9% +32.4% Nonresponse Nonresponse 126 2 +33.9% −35% Nonresponse Nonresponse 59 3 +26.5% +42% Nonresponse Nonresponse 89 4 −2.5% −43.9% Nonresponse<strong>Response</strong> 172 5 +17.5% +37% Nonresponse Nonresponse 95 6 +13.45% −53.8% Nonresponse<strong>Response</strong> 174 7 +.41% −29.8% Nonresponse Nonresponse 149 8 +6.2% −42.4% Nonresponse<strong>Response</strong> 461 9 +22.4% +73.6% Nonresponse Nonresponse 131 10 +14.3% −14.1% Nonresponse Nonresponse 57 11 −16.3% −44.8% Nonresponse<strong>Response</strong> 367 12 −24.7% −40.9% Nonresponse<strong>Response</strong> 487 13 +38.9% −5.5% Nonresponse Nonresponse 71 14 +30% +15.9% Nonresponse Nonresponse 281 15 +24.7% +20.5% Nonresponse Nonresponse 183</p><p>ADLA: attenuation distribution across the long axis; RECIST: Response Evaluation Criteria in Solid Tumors.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheAttenuationDistributionAcrosstheLongAxisADLA/1_1s20S1076633216001069.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheAttenuationDistributionAcrosstheLongAxisADLA/1_1s20S1076633216001069.jpg" alt="Figure 2, Kaplan-Meier survival curves demonstrating the ability of ADLA to discriminate patients with longer survival." class="lazyload" data-proofer-ignore></a></p><p>Table 2</p><p>Log-Rank Test Outcomes for Various ADLA Cutoff Thresholds</p><p>ADLA Cutoff Threshold Log-Rank Test <em>P</em> Value 0 0.228 −5% 0.228 −10% 0.081 −15% 0.081 −20% 0.081 −25% 0.081 −30% 0.053 −35% 0.012 −40% 0.012 −45% 0.973 −50% 0.973</p><p>ADLA, attenuation distribution across the long axis.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheAttenuationDistributionAcrosstheLongAxisADLA/2_1s20S1076633216001069.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TheAttenuationDistributionAcrosstheLongAxisADLA/2_1s20S1076633216001069.jpg" alt="Figure 3, A 51-year-old female with KRAS-mutated adenocarcinoma of the colon. CT imaging at baseline (a) and follow-up imaging (b) demonstrate a decrease in intralesional heterogeneity (ADLA measurements 18.2 and 7.71, respectively). Note that the lesion did not change significantly in size." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="acknowledgments"><span class="mr-2">Acknowledgments</span><a href="#acknowledgments" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Wahl R.L., Jacene H., Kasamon Y., et. al.: From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 2009; 50: pp. 122S-150S.</p><li><p>2. Barker A.D., Sigman C.C., Kelloff G.J., et. al.: I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin Pharmacol Ther 2009; 86: pp. 97-100.</p><li><p>3. Whisenant J.G., Sorace A.G., McIntyre J.O., et. al.: Evaluating treatment response using DW-MRI and DCE-MRI in trastuzumab responsive and resistant HER2-overexpressing human breast cancer xenografts. Transl Oncol 2014; 7: pp. 768-779.</p><li><p>4. Choi H., Charnsangavej C., de Castro Faria S., et. al.: CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol 2004; 183: pp. 1619-1628.</p><li><p>5. Abramson R.G., Li X., Hoyt T.L., et. al.: Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results. Magn Reson Imaging 2013; 31: pp. 1457-1464.</p><li><p>6. Hoyt K., Warram J.M., Umphrey H., et. al.: Determination of breast cancer response to bevacizumab therapy using contrast-enhanced ultrasound and artificial neural networks. J Ultrasound Med 2010; 29: pp. 577-585.</p><li><p>7. Eisenhauer E.A., Therasse P., Bogaerts J., et. al.: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: pp. 228-247.</p><li><p>8. Schneider C.A., Rasband W.S., Eliceiri K.W.: NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9: pp. 671-675.</p><li><p>9. Grothey A., Hedrick E.E., Mass R.D., et. al.: Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107. J Clin Oncol 2008; 26: pp. 183-189.</p><li><p>10. Chun Y.S., Vauthey J.-N., Boonsirikamchai P., et. al.: Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA 2009; 302: pp. 2338-2344.</p><li><p>11. Benjamin R.S., Choi H., Macapinlac H.A., et. al.: We should desist using RECIST, at least in GIST. J Clin Oncol 2007; 25: pp. 1760-1764.</p><li><p>12. Chung W.-S., Park M.-S., Shin S.J., et. al.: Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria. AJR Am J Roentgenol 2012; 199: pp. 809-815.</p><li><p>13. Smith A.D., Lieber M.L., Shah S.N.: Assessing tumor response and detecting recurrence in metastatic renal cell carcinoma on targeted therapy: importance of size and attenuation on contrast-enhanced CT. AJR Am J Roentgenol 2010; 194: pp. 157-165.</p><li><p>14. Yankeelov T.E., Lepage M., Chakravarthy A., et. al.: Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 2007; 25: pp. 1-13.</p><li><p>15. Yankeelov T.E., Luci J.J., Lepage M., et. al.: Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. Magn Reson Imaging 2005; 23: pp. 519-529.</p><li><p>16. Yaghmai V., Miller F.H., Rezai P., et. al.: Response to treatment series: part 2, tumor response assessment–using new and conventional criteria. AJR Am J Roentgenol 2011; 197: pp. 18-27.</p><li><p>17. Sahani D.V., Holalkere N.-S., Mueller P.R., et. al.: Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue–initial experience. Radiology 2007; 243: pp. 736-743.</p><li><p>18. Hylton N.M., Blume J.D., Bernreuter W.K., et. al.: Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy–results from ACRIN 6657/I-SPY TRIAL. Radiology 2012; 263: pp. 663-672.</p><li><p>19. Smith A.D., Shah S.N., Rini B.I., et. al.: Morphology, Attenuation, Size, and Structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy. AJR Am J Roentgenol 2010; 194: pp. 1470-1478.</p><li><p>20. Choi H., Charnsangavej C., Faria S.C., et. al.: Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 2007; 25: pp. 1753-1759.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-23/'>Volume 23</a>, <a href='/categories/issue-6/'>Issue 6</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=The%20Attenuation%20Distribution%20Across%20the%20Long%20Axis%20(ADLA)%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fthe-attenuation-distribution-across-the-long-axis-adla%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=The%20Attenuation%20Distribution%20Across%20the%20Long%20Axis%20(ADLA)%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fthe-attenuation-distribution-across-the-long-axis-adla%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fthe-attenuation-distribution-across-the-long-axis-adla%2F&text=The%20Attenuation%20Distribution%20Across%20the%20Long%20Axis%20(ADLA)%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/anatomic-eponyms-in-neuroradiology-brain-cerebral-vasculature-and-calvarium/"><div class="card-body"> <em class="small" data-ts="1464714000" data-df="ll" > May 31, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Anatomic Eponyms in Neuroradiology Brain, Cerebral Vasculature, and Calvarium</h3><div class="text-muted small"><p> Medical eponyms are ubiquitous, numerous, and at times controversial. They are often useful for succinctly conveying complex concepts, and familiarity with eponyms is important for proper usage and...</p></div></div></a></div><div class="card"> <a href="/posts/associations-between-nih-funding-and-advanced-bibliometric-indices-among-radiological-investigators/"><div class="card-body"> <em class="small" data-ts="1464714000" data-df="ll" > May 31, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Associations Between NIH Funding and Advanced Bibliometric Indices Among Radiological Investigators</h3><div class="text-muted small"><p> Rationale and Objectives Whereas data support the h index (reflecting both publications and citations) as an indicator of academic productivity, other advanced bibliometric indices aiming to addre...</p></div></div></a></div><div class="card"> <a href="/posts/descriptors-of-malignant-non-mass-enhancement-of-breast-mri/"><div class="card-body"> <em class="small" data-ts="1464714000" data-df="ll" > May 31, 2016 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Descriptors of Malignant Non-mass Enhancement of Breast MRI</h3><div class="text-muted small"><p> Rationale and Objectives This study aims to investigate the clinical significance of malignant non-mass enhancement (NME) descriptors in breast magnetic resonance images by assessing their correla...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/symptomatic-versus-asymptomatic-colorectal-cancer/" class="btn btn-outline-primary" prompt="Older"><p>Symptomatic Versus Asymptomatic Colorectal Cancer</p></a> <a href="/posts/the-impact-factor-of-radiological-journals-associations-with-journal-content-and-other-characterist/" class="btn btn-outline-primary" prompt="Newer"><p>The Impact Factor of Radiological Journals Associations with Journal Content and Other Characteristics Over a Recent 12-Year Period</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
